Publication | Closed Access

Generation of bcr-abl specific cytotoxic T-lymphocytes by using dendritic cells pulsed with bcr-abl (b3a2) peptide: its applicability for donor leukocyte transfusions in marrow grafted CML patients

Cell TherapyMedicineImmunologyHematologyBlood CellAutoimmunityCell TransplantationImmunotherapyDonor Leukocyte TransfusionsCell BiologyCml PatientsDendritic Cells